Skip to main content
Premium Trial:

Request an Annual Quote

Aurora, Merck Partner to Investigate Gene Function

Premium

SAN DIEGO--Aurora Biosciences has formed two new functional genomics collaborations with Merck in which Aurora will apply its GenomeScreen technology to investigate cell signaling pathways and gene function for selected Merck therapeutic programs. Aurora said GenomeScreen enables gene discovery, target identification, and signal pathway elucidation. Aurora will receive an upfront payment from Merck, possible additional research support fees, and certain provisions for revenues in the event that drugs developed through the collaboration are commercialized. Merck will receive a license to use in basic research and drug discovery the data and materials resulting from the deal.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.